NCT03936790View on ClinicalTrials.gov

Dose-response Study of Spinally Administered Ropivacaine for Caesarean Section in Tall Parturients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 2, 2019

Primary Completion Date

October 20, 2024

Study Completion Date

November 30, 2025

Conditions
Regional AnaesthesiaCesarean Section
Interventions
OTHER

Ropivacaine

In case of successful spinal anaesthesia, the dose of spinally administered ropivacaine will decrease by 0.375 mg for the next participant.In case of unsuccessful spinal anaesthesia, the dose of spinally administered ropivacaine will increase by 0.375 mg for the next participant.

OTHER

Fentanyl

A fix dose of fentanyl (15 mcg) will be co-administered spinally to all participants.

Trial Locations (1)

12462

2nd Department of Anesthesiology, Attikon University Hospital, Athens

All Listed Sponsors
lead

Paraskevi Matsota

OTHER